E-viri
Recenzirano
Odprti dostop
-
McCarthy, Philip L; Owzar, Kouros; Hofmeister, Craig C; Hurd, David D; Hassoun, Hani; Richardson, Paul G; Giralt, Sergio; Stadtmauer, Edward A; Weisdorf, Daniel J; Vij, Ravi; Moreb, Jan S; Callander, Natalie Scott; Van Besien, Koen; Gentile, Teresa; Isola, Luis; Maziarz, Richard T; Gabriel, Don A; Bashey, Asad; Landau, Heather; Martin, Thomas; Qazilbash, Muzaffar H; Levitan, Denise; McClune, Brian; Schlossman, Robert; Hars, Vera; Postiglione, John; Jiang, Chen; Bennett, Elizabeth; Barry, Susan; Bressler, Linda; Kelly, Michael; Seiler, Michele; Rosenbaum, Cara; Hari, Parameswaran; Pasquini, Marcelo C; Horowitz, Mary M; Shea, Thomas C; Devine, Steven M; Anderson, Kenneth C; Linker, Charles
The New England journal of medicine, 05/2012, Letnik: 366, Številka: 19Journal Article
In patients who had undergone stem-cell transplantation, lenalidomide maintenance therapy improved progression-free and overall survival, though at the expense of some increased hematologic toxicity and second malignant tumors. A goal of therapy for multiple myeloma, to induce complete remission and prolong survival, is usually accomplished with combination therapy. 1 , 2 Autologous hematopoietic stem-cell transplantation is often used after induction chemotherapy to improve the response or to consolidate complete remission. 1 , 2 However, since most patients with multiple myeloma have disease recurrence or progression after transplantation, maintenance therapies have been used to prolong complete remission and prevent relapse or progressive disease. Low-dose melphalan, interferon alfa, and glucocorticoids have been used for maintenance after primary therapy, but their long-term use is limited by toxicity and modest efficacy. 3 – 6 Five studies involving patients who . . .
Avtor
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.